FDA Temporarily suspends bird flu testing program amid organizational changes

The Food and Drug Administration (FDA) has announced a temporary suspension of its bird flu testing improvement program. This decision arises amidst significant organizational changes, including staff layoffs. These adjustments have led to the disruption of various initiatives within the agency.

The bird flu testing program, in which QuoData is involved as a key contributor, providing study design and statistical evaluation, is crucial for ensuring effective detection and management of avian influenza outbreaks, which pose significant risks to both public health and agriculture.

The FDA emphasized its commitment to the program and assured stakeholders that efforts are underway to resume operations promptly.

This pause is primarily attributed to recent internal restructuring aimed at optimizing agency functions. The FDA is actively working to address these challenges and reinforce its testing capabilities. The agency remains dedicated to safeguarding public health and mitigating potential risks associated with avian diseases.

Source: https://www.cbsnews.com/news/fda-bird-flu-testing-efforts-disrupted-rfk-jr-layoffs/